Concepedia

Sachin Vadgama

SV

6

Publications

99

Citations

6

H-Index

2019

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Kite (United States)

Gilead Sciences (United Kingdom)

University College London

Sachin Vadgama is an author at Memorial Sloan Kettering Cancer Center specializing in cancer research, cell transplantation, and oncology.

ORCID

Top concepts

Publications per year

2019–2025

6

Publications

6

The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Therapy in Patients with Large B-Cell Lymphoma in the United States: An Economic Evaluation of the ZUMA-7 Trial

Miguel‐Angel Perales, John Kuruvilla, Julia Thornton Snider et al. · Transplantation and Cellular Therapy · 2022 · 31 citations · Full text

, , +19

An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States

Olalekan O. Oluwole, Anik R. Patel, Sachin Vadgama et al. · Journal of Medical Economics · 2023 · 17 citations · Full text

Predicting Survival for Chimeric Antigen Receptor T-Cell Therapy: A Validation of Survival Models Using Follow-Up Data From ZUMA-1

Sachin Vadgama, Jess Mann, Zahid Bashir et al. · Value in Health · 2022 · 14 citations · Full text

Axicabtagene ciloleucel compared to standard of care in Swedish patients with large B-cell lymphoma: a cost-effectiveness analysis of the ZUMA-7 trial

Anne Sofie Ledgaard Loftager, Anne Danø, Oskar Eklund et al. · Journal of Medical Economics · 2023 · 13 citations · Full text

Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole–body magnetic resonance imaging in radio-recurrent prostate cancer

Sola Adeleke, Arash Latifoltojar, Harbir Sidhu et al. · BMC Medical Imaging · 2019 · 12 citations · Full text

Rows per page

1–5 of 6